New evidence of a causal link between herpes viruses and Alzheimer’s reinvigorates research into the possible role of infections — and their treatment — in the disease
What causes Alzheimer’s disease? The answer could be right under our noses, says leading expert Professor Ruth Itzhaki. Her latest paper presents a lifetime of research evidence that the herpes virus responsible for cold sores can also cause Alzheimer’s – and new data which show antiviral drugs drastically reduce risk of senile dementia in patients with severe herpes infections. The review in Frontiers in Ageing Neuroscience raises the tantalizing prospect of a simple, effective preventive treatment for one of humanity’s costliest disorders.
The HSV1 theory of Alzheimer’s disease
Herpes viruses are the dreaded ‘gift that keeps on giving’. They remain lifelong in our neurons and immune cells, reactivating and resurfacing in characteristic blisters when we’re run down by stress or illness. Most people are infected by Herpes Simplex Virus 1 (HSV1) by the time they reach old age.
But what happens to infected neurons in our brain during this reactivation?
“HSV1 could account for 50% or more of Alzheimer’s disease cases,” says Professor Itzhaki, who has spent over 25 years at the University of Manchester investigating a potential link.
HSV1 is better known as the cause of cold sores. Itzhaki has shown previously that cold sores occur more frequently in carriers of APOE-?4 – a gene variant that confers increased risk of Alzheimer’s.
“Our theory is that in APOE-?4 carriers, reactivation is more frequent or more harmful in HSV1-infected brain cells, which as a result accumulate damage that culminates in development of Alzheimer’s.”
Proving the theory
Few countries collect the population data required to test this theory – for example, to find out whether antiviral treatments reduce dementia risk.
In Taiwan however, researchers have done just that. There, 99.9% of the population is enrolled in a National Health Insurance Research Database, which is being extensively mined for information on microbial infections and disease. In 2017-2018 three studies were published describing Taiwanese data on the development of senile dementia – of which Alzheimer’s is the main cause – and the treatment of patients with marked overt signs of infection with HSV or varicella zoster virus (VZV, the chickenpox virus).
“The striking results include evidence that the risk of senile dementia is much greater in those who are infected with HSV, and that anti-herpes antiviral treatment causes a dramatic decrease in number of those subjects severely affected by HSV1 who later develop dementia.”
Previous findings from Itzhaki’s own research group provide a mechanistic link which supports these epidemiological findings. They found that HSV1 causes protein deposits characteristic of Alzheimer’s: ‘plaques’ between neurons, and ‘tangles’ inside of them.
“Viral DNA is located very specifically within plaques in postmortem brain tissue from Alzheimer’s sufferers. The main proteins of both plaques and tangles accumulate also in HSV1-infected cell cultures – and antiviral drugs can prevent this.”
Towards a cure
“It should be stressed that the results of these Taiwanese studies apply only to severe HSV1 (or VZV) infections, which are rare,” admits Itzhaki. “Ideally, we would study dementia rates amongst people who have suffered mild HSV1 infection, including herpes labialis (cold sores) or mild genital herpes, but these are far less likely to be documented.”
Although further work is needed to confirm and define a causal link between HSV1 infection and Alzheimer’s, Itzhaki is enthusiastic about the treatment prospects.
“Considering that over 150 publications strongly support an HSV1 role in Alzheimer’s, these Taiwan findings greatly justify usage of antiherpes antivirals – which are safe and well-tolerated – to treat Alzheimer’s disease.
“They also incentivize development of an HSV1 vaccine, which would likely be the most effective treatment.”
This echoes the growing use worldwide of human papillomavirus (HPV) vaccination to prevent cervical cancer – another virus-disease link which emerged in a similar process of research.
Learn more: Does herpes cause Alzheimer’s?
The Latest on: HSV1 vaccine
via Google News
The Latest on: HSV1 vaccine
- New study bolsters hypothesis that herpes virus causes Alzheimer's on October 21, 2018 at 5:57 pm
The evidence is still primarily observational, with no clear causal link reasonably established, but Itzhaki suggests the growing body of data is convincing enough to expand research into development ... […]
- Does herpes cause Alzheimer’s? on October 19, 2018 at 7:30 am
“They also incentivize development of an HSV1 vaccine, which would likely be the most effective treatment.” This echoes the growing use worldwide of human papillomavirus (HPV) vaccination to prevent c... […]
- Herpes Vaccine Study on June 25, 2018 at 8:14 am
To participate, women must be generally healthy, between 18 and 30 and test negative for both HSV-1 and HSV-2. Some of the participants will receive the herpes vaccine and others will receive an inves... […]
- Efficacy Results of a Trial of a Herpes Simplex Vaccine on March 14, 2018 at 5:00 pm
Two previous studies of a herpes simplex virus type 2 (HSV-2) subunit vaccine containing glycoprotein D in HSV-discordant couples revealed 73% and 74% efficacy against genital disease in women who wer... […]
- Puff, Puff, Pass: New Vaccine Could Help Herpes-Suffering Stoners on March 13, 2017 at 10:31 am
With over 50 percent of the American population suffering from herpes simplex virus type 1 (HSV-1), the risk is not impossible ... Called Theravax and manufactured by biotech company Rational Vaccines ... […]
- Vaccine Fails to Protect Against Herpes Infection on January 8, 2012 at 2:15 pm
The vaccine was designed to protect women against two forms of herpes, HSV1 and HSV2, and involved more than 8000 women between ages 18 and 30. Previous studies had shown the shot provided some protec... […]
- Vaccine Helps Prevent HSV-1 Genital Disease and Infection on January 5, 2012 at 9:29 am
HealthDay News—An investigational vaccine effectively prevents herpes simplex virus type 1 (HSV-1) but not HSV type 2 (HSV-2) genital disease and infection, according to a study published in the Jan. ... […]
- Study Dashes Herpes Vaccine Hopes on January 4, 2012 at 3:10 pm
Read this story on www.medpagetoday.com. The vaccine showed some efficacy against herpes simplex-1 (HSV-1), but not against herpes simplex-2 (HSV-2), the researchers reported. Since both viruses are c... […]
- Research shows progress toward a genital herpes vaccine on January 3, 2012 at 4:00 pm
We were partially successful against half of the equation – protecting women from genital disease caused by HSV-1," said Robert Belshe, M.D., director of the Saint Louis University Center for Vaccine ... […]
via Bing News